latest news releases from the newsroom
Universal Capital Management, Inc.
Universal Capital Management, Inc. Reports That SIVOO Has Partnered With Three Leading Innovators in Online Advertising and Technology
WILMINGTON, Del., Feb. 7, 2007 (PRIME NEWSWIRE) -- Universal Capital Management, Inc. (OTCBB:UCMT), a Business Development Company which provides emerging growth companies with management and strategic resources for successful growth, reported today that SIVOO Holdings Inc. ("SIVOO"), a significant holding among its portfolio holdings, has partnered with Avenue A/Razorfish, WebTrends and 24/7 Real Media.
Beceem Raises Over $40 Million in Series D-Round Financing; NEC Joins as Strategic Investor
SANTA CLARA, Calif., Feb. 7, 2007 (PRIME NEWSWIRE) -- Beceem Communications (www.beceem.com), the leading provider for Mobile WiMAX chipsets, today announced that it has raised more than $40 million in Series D-round financing that will enable Beceem to expand its leadership position in the Mobile WiMAX market. The round was led by Teachers' Private Capital and joined by NEC Corporation, a new investor in Beceem, adding to the company's list of strategic investors.
Crown Crafts, Inc.
Crown Crafts, Inc. to Announce Results for Third Quarter of Fiscal Year 2007
GONZALES, La., Feb. 7, 2007 (PRIME NEWSWIRE) -- Crown Crafts, Inc. (OTCBB:CRWS) intends to release the results of its operations for the third quarter of fiscal year 2007 before the market opens on Wednesday, February 14, 2007. E. Randall Chestnut, Chairman, President and Chief Executive Officer, and Amy Vidrine Samson, Chief Financial Officer, will host a teleconference at 1:00 p.m. Central Standard Time on that same day to discuss the Company's results and answer appropriate questions from stockholders.
Actavis Launches Sertraline Tablets in the U.S.
REYKJAVIK, Iceland, Feb. 7, 2007 (PRIME NEWSWIRE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Sertraline Hydrochloride tablets. Distribution of the product will commence immediately.